A Study To Investigate The Safety, Tolerability And Blood Levels Of GSK598809

Clinical trial NCT00437840 · COMPLETED

Trial details

NCT number: NCT00437840
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Substance Dependence

Start date: 2007-03-20
Primary completion: 2007-06-20
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.